Hafedh Dekhil

515 citations
13 papers · 387 indexed · h-index 10
Topics
Wnt/β-catenin signaling in development and cancer (3 papers)Adipokines, Inflammation, and Metabolic Diseases (2 papers)HER2/EGFR in Cancer Research (2 papers)
Partner nations
CanadaSaudi ArabiaItaly

In The Last Decade

Hafedh Dekhil

13 papers receiving 378 citations

Peers

Hafedh Dekhil
Comparison fields: 5 of 71
  • Molecular Biology 212
  • Oncology 86
  • Cell Biology 50
  • Epidemiology 43
  • Plant Science 41
Replace Dongfeng Zhao with:
Dongfeng Zhao China
Frédéric Massicotte Canada
Zheng Xu China
Jin Na Shin United States
Lechuang Chen China
Frederic Bone United States
Vincenzo Giansanti Italy
Siyuan Yin China
Shu-Hui Lin Taiwan
Hafedh Dekhil relative to Dongfeng Zhao China Dongfeng Zhao's profile →
Citations per field
00.5×1.5×2.1×
Dongfeng Zhao · 1×
Citations per year

Countries citing papers authored by Hafedh Dekhil

Since Specialization
Citations

This map shows the geographic impact of Hafedh Dekhil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hafedh Dekhil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hafedh Dekhil more than expected).

Fields of papers citing papers by Hafedh Dekhil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hafedh Dekhil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hafedh Dekhil. The network helps show where Hafedh Dekhil may publish in the future.

Co-authorship network of co-authors of Hafedh Dekhil

This figure shows the co-authorship network connecting the top 25 collaborators of Hafedh Dekhil. A scholar is included among the top collaborators of Hafedh Dekhil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hafedh Dekhil. Hafedh Dekhil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 5
2 13
3 1
4 9
5 16
6 44
7 40
8 41
9 35
10 49
11 18
12 94
13 22

About Hafedh Dekhil

Hafedh Dekhil is a scholar working on Orthopedics and Sports Medicine, Hematology and Cell Biology, having authored 13 papers that have together received 387 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (3 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (86 citations), Molecular Biology (212 citations) and Cell Biology (50 citations). Hafedh Dekhil has collaborated with scholars based in Canada, Saudi Arabia and Italy. Frequent co-authors include Carlo Gambacorti‐Passerini, Cathy Lan, Amber Yasmeen, Daniela Benati, Annamaria De Filippo, Addolorata Maria Luce Coluccia, Amal Alachkar, Mustapha Kandouz, Ala‐Eddin Al Moustafa and Assim A. Alfadda. Their work appears in journals such as Biochemistry, Cancer Research and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026